Internal Medicine, Gastroenterology · Flushing, NY
NPI
1447316104
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
41 61 Kissena Blvd, Suite # 27
Flushing, NY, 11355
Phone (718) 461-6212
Medicare paid, 2024
$35K
171 services
Medicare patients, 2024
79
Average age 75
Drug cost, 2024
$290K
1,244 prescriptions
Company payments, 2025
$7,082
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Chang Ho Suk was code 99213 (office e&m - established), 61 times for 54 patients. In total Chang Ho Suk billed 171 services in 11 codes, and Medicare paid $35K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 61 | 54 | $69.33 | $4,229 |
| 43239 Upper GI Endoscopy | Office | 56 | 55 | $339.02 | $19K |
| 45378 Lower GI Endoscopy - Other | Office | 15 | 15 | $290.19 | $4,353 |
| 99214 Office E&M - Established | Office | 14 | 14 | $106.07 | $1,485 |
By year: 2022 $51K for 221 services; 2023 $34K for 161 services; 2024 $35K for 171 services.
Medicare prescription drug claims, 2024
In 2024, the drug Chang Ho Suk prescribed most often to Medicare patients was Esomeprazole Magnesium, with 543 prescriptions and refills. In total Chang Ho Suk wrote 1,244 Medicare prescriptions that cost $290K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Esomeprazole Magnesium Generic | 543 | 633 | 177 | $7,266 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 134 | 134 | 132 | $8,916 |
| Pantoprazole Sodium Generic | 85 | 96 | 18 | $358 |
| Vemlidy Tenofovir Alafenamide | 84 | 100 | 11 | $142K |
| Famotidine Generic | 64 | 66 | 17 | $560 |
| Omeprazole Generic | 62 | 68 | 18 | $684 |
| Dexlansoprazole Dr Dexlansoprazole | 46 | 60 | 15 | $9,529 |
| Sucralfate Generic | 30 | 30 | 12 | $2,202 |
| Tenofovir Disoproxil Fumarate Generic | 29 | 35 | Under 11 | $3,562 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 21 | 21 | 21 | $225 |
| Rosuvastatin Calcium Generic | 19 | 31 | Under 11 | $72.54 |
| Baraclude Entecavir | 13 | 13 | Under 11 | $18K |
Brand drugs: 156 claims; generic drugs: 1,088 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chang Ho Suk $7,082 ($7,082 in general payments such as food, travel and fees) from 7 companies. The largest payer was Gilead Sciences, Inc. with $6,008.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.